TGA Approval

OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection (288223)

ARTG ID

288223

ARTG Name

OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection

Sponsor

Maxx Pharma Pty Ltd

ARTG Date

December 11, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Maxx Pharma Pty Ltd

https://medical-cdn.nocode.com/drug_tga/a1811238de9d0e28753eaed58556131e.pdf

https://medical-cdn.nocode.com/drug_tga/c6fe51b9645d0783b9b704e1b2d1a0fe.pdf

Ingredient Name

Trastuzumab

Empowering clinical research with data-driven insights and AI-powered tools.

OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection (288223) - TGA 批准文号 | MedPath